Skip to main content

Animations

MJFF Publications

7101 - 7110 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2020
  • 2025
  • 2024
  • 2014
  • 2024
  • 2024
  • 2024
  • 2024
  • 2025
  • Summary Details
    RESTRICTED
    Title: Epigenomic profile of GBA1 in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108066
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28175
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Cropland associated with risk of Parkinson's disease in the northern Great Plains
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107288
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Functional ataxia in a specialized ataxia center
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106006
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Post‐Traumatic Shoulder Movement Disorders: A Challenging Differential Diagnosis Between Organic and Functional
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12016
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00840-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00723-x
    Citation Count: 5
  • Summary Details
    OPEN
    Title: USP14 inhibition enhances Parkin-independent mitophagy in iNeurons
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.phrs.2024.107484
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae163
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Reply to: “Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.30247
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.